3,439
Views
59
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Rothia mucilaginosa pneumonia: a literature review

&
Pages 125-129 | Received 18 Jul 2014, Accepted 21 Oct 2014, Published online: 09 Feb 2015

References

  • Collins MD, Hutson RA, Båverud V, Falsen E. Characterization of a Rothia-like organism from a mouse: Rothia nasimurium sp. nov. and reclassification of Stomatococcus mucilaginosus as Rothia mucilaginosa comb. nov. Int J Syst Evol Microbiol 2000;3:1247–51.
  • Uchibori S, Tsuzukibashi O, Kobayashi T, Aida M. Localization of the genus Rothia in the oral cavity. Int J Oral Med Sci 2012;11:207–10.
  • Rubin SJ, Lyons RW, Murcia AJ. Endocarditis associated with cardiac catheterization due to a gram-positive coccus designated Micrococcus mucilaginosus incertae sedis. J Clin Microbiol 1978;7:546–9.
  • Ascher DP, Zbick C, White C, Fischer GW. Infections due to Stomatococcus mucilaginosus: 10 cases and review. Rev Infect Dis 1991;13:1048–52.
  • Henwick S, Koehler M, Patrick CC. Complications of bacteremia due to Stomatococcus mucilaginosus in neutropenic children. Clin Infect Dis 1993;17:667–71.
  • Faiad G, Singh M, Narasimhan A, Mendez M, Shama S, Nassar N. Rothia mucilaginosa life threatening infections in non-neutropenic hosts. Open Journal of Internal Medicine 2011;1:68–71.
  • Patey O, Malkin JE, Coutaux A, Leflour N, Lafaix C, Emond JP, et al. AIDS-related Stomatococcus mucilaginosus infection. Lancet 1991;338:631–2.
  • Cunniffe JG, Mallia C, Alcock PA. Stomatococcus mucilaginosus lower respiratory tract infection in a patient with AIDS. J Infect 1994;29:327–30.
  • Sánchez-Carrillo C, Cercenado E, Cibrián F, Bouza E. Stomatococcus mucilaginosus pneumonia in a liver-transplant patient. Clin Microbiol Newslett 1995;17:54–5.
  • Gruson D, Hilbert G, Pigneux A, Vargas F, Guisset O, Texier J, et al. Severe infection caused by Stomatococcus mucilaginosus in a neutropenic patient: case report and review of the literature. Hematol Cell Ther 1998;40:167–9.
  • Lambotte O, Debord T, Soler C, Roué R. Pneumonia due to Stomatococcus mucilaginosus in an AIDS patient. Clin Microbiol Infect 1999;5:112–14.
  • Korsholm TL, Haahr V, Prag J. Eight cases of lower respiratory tract infection caused by Stomatococcus mucilaginosus. Scand J Infect Dis 2007;39:913–17.
  • Fusconi M, Conti C, De Virgilio A, de Vincentiis M. [Paucisymptomatic pneumonia due to Rothia mucilaginosa: case report and literature review.] Infez Med 2009;17:100–4 (in Italian).
  • Chavan RS, Pannaraj PS, Luna RA, Szabo S, Adesina A, Versalovic J, et al. Significant morbidity and mortality attributable to Rothia mucilaginosa infections in children with hematological malignancies or following hematopoietic stem cell transplantation. Pediatr Hematol Oncol 2013; 30:445–54.
  • Cho EJ, Sung H, Park SJ, Kim MN, Lee SO. Rothia mucilaginosa diagnosed by quantitative cultures and intracellular organisms of bronchoalveolar lavage in a lymphoma patient. Ann Lab Med 2013;33:145–9.
  • Ramos JM, Mateo I, Vidal I, Rosillo EM, Merino E, Portilla J. Infection due to Rothia mucilaginosa. A respiratory pathogen? Enferm Infecc Microbiol Clin 2014;32:306–9.
  • Baeza Martinez C, Zamora Molina L, García Sevila R, Gil Carbonell J, Ramos Rincon JM, Martin Serrano C. [Rothia mucilaginosa pneumonia in an immunocompetent patient.] Arch Bronconeumol 2014;50:493–5 (in Spanish)
  • Ruoff KL. Miscellaneous catalase-negative, gram-positive cocci: emerging opportunists. J Clin Microbiol 2002;40:1129–33.
  • Monsó E, Ruiz J, Rosell A, Manterola J, Fiz J, Morera J, et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995;152:1316–20.
  • Reynolds HY, Elias JA. Pulmonary defense mechanisms against infections. In: Fishman AP, editor. Fishman's pulmonary diseases and disorders. McGraw-Hill; 1998 pp 265–74.
  • Pinsky RL, Piscitelli V, Patterson JE. Endocarditis caused by relatively penicillin-resistant Stomatococcus mucilaginosus. J Clin Microbiol 1989;27:215–16.
  • Von Eiff C, Herrmann M, Peters G. Antimicrobial susceptibilities of Stomatococcus mucilaginosus and of Micrococcus spp. Antimicrob Agents Chemother 1995;39:268–70.
  • Piper KE, Steckelberg JM, Patel P. In vitro activity of daptomycin against clinical isolates of Gram-positive bacteria. J Infect Chemother 2005;11:207–9.
  • Von Eiff C, Peters G. In vitro activity of ciprofloxacin, ofloxacin and levofloxacin against Micrococcus species and Stomatococcus mucilaginosus isolated from healthy subjects and neutropenic patients. Eur J Clin Microbiol Infect Dis 1998;17:890–2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.